-
-
-
-
Description
- based on the active segment of histatin 5 protein found in human saliva
-
-
Target Organism
-
- No MICs found on DRAMP database
-
-
Medical use
- Oral candidiasis in HIV seropositive patients
-
Company
- Pacgen(Vancouver, BC, Canada)
-
Stage of Development
- Phase IIb
-
- Current treatments for Candida infections are either only marginally efficacious, have poor patient compliance characteristics, can cause serious side effects, can lead to drug-resistance and/or have multiple drug interaction issues.Phase IIb results: 34% increase in primary end point efficacy level; Phase III trial not initiated
-
Clinical Trials
- NCT00659971